S&P 500   3,132.65 (-0.11%)
DOW   27,864.21 (-0.16%)
QQQ   203.93 (-0.07%)
AAPL   267.13 (+0.08%)
FB   201.72 (+0.19%)
MSFT   151.07 (-0.19%)
GOOGL   1,339.31 (-0.27%)
AMZN   1,745.16 (-0.25%)
CGC   21.19 (-0.47%)
NVDA   212.43 (+0.12%)
MU   47.17 (+1.53%)
BABA   200.05 (+0.66%)
GE   10.95 (-0.36%)
TSLA   341.02 (+0.44%)
T   37.98 (-0.16%)
AMD   38.99 (+0.15%)
ACB   2.62 (+0.00%)
F   9.00 (-0.22%)
PRI   135.47 (+0.09%)
NFLX   296.47 (-1.99%)
BAC   33.36 (-0.45%)
GILD   66.58 (-0.52%)
DIS   145.60 (-0.42%)
S&P 500   3,132.65 (-0.11%)
DOW   27,864.21 (-0.16%)
QQQ   203.93 (-0.07%)
AAPL   267.13 (+0.08%)
FB   201.72 (+0.19%)
MSFT   151.07 (-0.19%)
GOOGL   1,339.31 (-0.27%)
AMZN   1,745.16 (-0.25%)
CGC   21.19 (-0.47%)
NVDA   212.43 (+0.12%)
MU   47.17 (+1.53%)
BABA   200.05 (+0.66%)
GE   10.95 (-0.36%)
TSLA   341.02 (+0.44%)
T   37.98 (-0.16%)
AMD   38.99 (+0.15%)
ACB   2.62 (+0.00%)
F   9.00 (-0.22%)
PRI   135.47 (+0.09%)
NFLX   296.47 (-1.99%)
BAC   33.36 (-0.45%)
GILD   66.58 (-0.52%)
DIS   145.60 (-0.42%)
S&P 500   3,132.65 (-0.11%)
DOW   27,864.21 (-0.16%)
QQQ   203.93 (-0.07%)
AAPL   267.13 (+0.08%)
FB   201.72 (+0.19%)
MSFT   151.07 (-0.19%)
GOOGL   1,339.31 (-0.27%)
AMZN   1,745.16 (-0.25%)
CGC   21.19 (-0.47%)
NVDA   212.43 (+0.12%)
MU   47.17 (+1.53%)
BABA   200.05 (+0.66%)
GE   10.95 (-0.36%)
TSLA   341.02 (+0.44%)
T   37.98 (-0.16%)
AMD   38.99 (+0.15%)
ACB   2.62 (+0.00%)
F   9.00 (-0.22%)
PRI   135.47 (+0.09%)
NFLX   296.47 (-1.99%)
BAC   33.36 (-0.45%)
GILD   66.58 (-0.52%)
DIS   145.60 (-0.42%)
S&P 500   3,132.65 (-0.11%)
DOW   27,864.21 (-0.16%)
QQQ   203.93 (-0.07%)
AAPL   267.13 (+0.08%)
FB   201.72 (+0.19%)
MSFT   151.07 (-0.19%)
GOOGL   1,339.31 (-0.27%)
AMZN   1,745.16 (-0.25%)
CGC   21.19 (-0.47%)
NVDA   212.43 (+0.12%)
MU   47.17 (+1.53%)
BABA   200.05 (+0.66%)
GE   10.95 (-0.36%)
TSLA   341.02 (+0.44%)
T   37.98 (-0.16%)
AMD   38.99 (+0.15%)
ACB   2.62 (+0.00%)
F   9.00 (-0.22%)
PRI   135.47 (+0.09%)
NFLX   296.47 (-1.99%)
BAC   33.36 (-0.45%)
GILD   66.58 (-0.52%)
DIS   145.60 (-0.42%)
Log in

NASDAQ:ROCM - Rochester Medical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Rochester Medical Corporation develops, manufactures and markets a range of polyvinyl chloride (PVC)-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets. The Company's extended care products include a range of male external catheters (MECs) for managing male urinary incontinence and a range of intermittent catheters for managing both male and female urinary retention. Along with its silicone male external catheters, it also sells a range of latex male external catheters in the United Kingdom. Its Magic3 is a range of silicone intermittent catheters. Its extended care products also include the FemSoft Insert, a soft, liquid-filled, conformable urethral insert for managing female stress urinary incontinence in adult females. Effective November 14, 2013, CR Bard Inc acquired the entire share capital of Rochester Medical Corp.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Supplies
SectorN/A
Current SymbolNASDAQ:ROCM
CUSIP77149710
WebN/A
Phone+1-507-5339600

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ROCM News and Ratings via Email

Sign-up to receive the latest news and ratings for ROCM and its competitors with MarketBeat's FREE daily newsletter.


Rochester Medical (NASDAQ:ROCM) Frequently Asked Questions

What is Rochester Medical's stock symbol?

Rochester Medical trades on the NASDAQ under the ticker symbol "ROCM."

Has Rochester Medical been receiving favorable news coverage?

News headlines about ROCM stock have trended negative on Tuesday, according to InfoTrie. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Rochester Medical earned a coverage optimism score of -2.0 on InfoTrie's scale. They also assigned media coverage about the healthcare company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Rochester Medical.

Who are some of Rochester Medical's key competitors?

How can I contact Rochester Medical?

Rochester Medical's mailing address is 1 Rochester Medical Dr NW, STEWARTVILLE, MN 55976-1647, United States. The healthcare company can be reached via phone at +1-507-5339600.


MarketBeat Community Rating for Rochester Medical (NASDAQ ROCM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  70 (Vote Underperform)
Total Votes:  128
MarketBeat's community ratings are surveys of what our community members think about Rochester Medical and other stocks. Vote "Outperform" if you believe ROCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ROCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel